Delta Capital Management LLC Trims Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Delta Capital Management LLC lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,005 shares of the healthcare conglomerate’s stock after selling 245 shares during the period. UnitedHealth Group accounts for about 1.4% of Delta Capital Management LLC’s holdings, making the stock its 13th biggest position. Delta Capital Management LLC’s holdings in UnitedHealth Group were worth $3,669,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of the company. Capital & Planning LLC lifted its holdings in shares of UnitedHealth Group by 19.2% in the 4th quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate’s stock worth $248,000 after acquiring an additional 79 shares during the last quarter. Brighton Jones LLC lifted its position in shares of UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after purchasing an additional 28,231 shares during the period. Union Bancaire Privee UBP SA purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth about $27,233,000. Revolve Wealth Partners LLC lifted its position in shares of UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after purchasing an additional 2,324 shares during the period. Finally, Van ECK Associates Corp lifted its position in shares of UnitedHealth Group by 12.6% in the 4th quarter. Van ECK Associates Corp now owns 196,907 shares of the healthcare conglomerate’s stock worth $99,607,000 after purchasing an additional 22,059 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $318.14 on Friday. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $288.60 billion, a P/E ratio of 20.53, a PEG ratio of 1.37 and a beta of 0.45. The firm’s 50 day moving average is $391.47 and its two-hundred day moving average is $476.22.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same quarter last year, the firm posted $6.91 EPS. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be given a $2.21 dividend. The ex-dividend date is Monday, June 16th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a dividend yield of 2.78%. UnitedHealth Group’s dividend payout ratio is presently 37.02%.

Insider Activity

In other UnitedHealth Group news, CEO Stephen J. Hemsley bought 86,700 shares of the business’s stock in a transaction that occurred on Friday, May 16th. The shares were acquired at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the transaction, the chief executive officer now directly owns 679,493 shares in the company, valued at approximately $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director John H. Noseworthy bought 300 shares of the company’s stock in a transaction that occurred on Wednesday, May 14th. The shares were bought at an average price of $312.16 per share, for a total transaction of $93,648.00. Following the transaction, the director now directly owns 6,063 shares in the company, valued at $1,892,626.08. This trade represents a 5.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased 109,408 shares of company stock valued at $31,607,768 over the last ninety days. 0.28% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

UNH has been the subject of several research analyst reports. Wells Fargo & Company reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research report on Friday, June 6th. Morgan Stanley decreased their price target on shares of UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating for the company in a research note on Wednesday, May 14th. Piper Sandler decreased their price target on shares of UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating for the company in a research note on Tuesday, June 3rd. Mizuho reduced their price objective on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a research note on Friday, May 16th. Finally, HSBC reaffirmed a “reduce” rating and set a $270.00 price target (down previously from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. One analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $426.52.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.